# EDGAR Filing Document

**Accession Number:** 0001986247
**File Stem:** 0001213900-26-024438
**Filing Date:** 2026-3
**Character Count:** 2924
**Document Hash:** af78ac05d7b0f843c1a0d4720c6e92ef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-024438.hdr.sgml**: 20260306

**ACCESSION NUMBER**: 0001213900-26-024438

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260306

**FILED AS OF DATE**: 20260306

**DATE AS OF CHANGE**: 20260306

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Park Ha Biological Technology Co., Ltd.
- **CENTRAL INDEX KEY:** 0001986247
- **STANDARD INDUSTRIAL CLASSIFICATION:** SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** F4
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42453
- **FILM NUMBER:** 26729406

**BUSINESS ADDRESS:**
- **STREET 1:** NO. 50 XIUXI ROAD
- **STREET 2:** 14F, BUILDING 3
- **CITY:** WUXI CITY
- **STATE:** F4
- **ZIP:** 214135
- **BUSINESS PHONE:** 864000127562

**MAIL ADDRESS:**
- **STREET 1:** NO. 50 XIUXI ROAD
- **STREET 2:** 14F, BUILDING 3
- **CITY:** WUXI CITY
- **STATE:** F4
- **ZIP:** 214135

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of March 2026

Commission File No. 001-42453

**PARK HA BIOLOGICAL TECHNOLOGY CO., LTD.**

(Translation of registrant's name into English)

**901, Building C<br> Phase 2, Wuxi International Life Science Innovation Campus<br> 196 Jinghui East Road<br> Xinwu District, Wuxi, Jiangsu Province<br> People's Republic of China 214000**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

On March 6, 2026, Park Ha Biological Technology Co., Ltd. (the "Company") received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") stating that because the Company's Class A ordinary shares had a closing bid price at or above $1.00 per share for 10 consecutive business days, from February 20 through March 5, 2026, the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), and that the matter is now closed.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 6, 2026

---

| | |
|:---|:---|
| Park Ha Biological Technology Co., Ltd. | Park Ha Biological Technology Co., Ltd. |
| By: | */s/ Xiaoqiu Zhang* |
| Name: | Xiaoqiu Zhang |
| Title: | Chief Executive Officer and<br> Chairperson of the Board |

---